Sunrest Lifescience (NSE:SUNREST) Stock Based Compensation: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNREST Sunrest Lifescience Ltd NSE:SUNREST
42 GF Score
Price ₹35.00
! 5 Warning Signs
View Full Analysis

What is Sunrest Lifescience Stock Based Compensation?

Sunrest Lifescience NSE:SUNREST 42 Stock Based Compensation is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:SUNREST with a GF Score™ of 42/100. The stock has 5 warning signs investors should review.

Sunrest Lifescience's Stock Based Compensation for the six months ended in Mar. 2026 was ₹0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Sunrest Lifescience Stock Based Compensation Related Terms

Sunrest Lifescience Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Sunrest Lifescience's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience Stock Based Compensation Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SUNREST
42GF Score
Sunrest Lifescience Ltd NSE:SUNREST
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunrest Lifescience Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

What does a Stock Based Compensation of ₹0.0 Mil mean?
Sunrest Lifescience (NSE:SUNREST) has a Stock Based Compensation of ₹0.0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Sunrest Lifescience and its competitors.
Is Sunrest Lifescience's Stock Based Compensation too high?
Sunrest Lifescience's current Stock Based Compensation is ₹0.0 Mil. Overall, Sunrest Lifescience has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Stock Based Compensation compare to competitors?
Sunrest Lifescience's Stock Based Compensation of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Sunrest Lifescience and its competitors. Sunrest Lifescience's current Stock Based Compensation is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Stock Based Compensation of ₹0.0 Mil. The current Stock Based Compensation is ₹0.0 Mil. Sunrest Lifescience's overall GF Score™ is 42/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Stock Based Compensation is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunrest Lifescience Business Description

Address YMCA Club, Near SG Highway, D-608 West Gate, Near Brooklin Tower, Makarba, Jivraj Park, Ahmedabad, GJ, IND, 380051
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
42GF Score

Get the complete analysis for NSE:SUNREST

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.00
Price